syndicate

Spyre Therapeutics Announces Pricing of $275.0 Million Public Offering of Common Stock

WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology…

1 week ago

Demand AI Group Secures $2.5 Million in Funding from International Institutional and Local Investors

DENVER, Sept. 12, 2025 /PRNewswire/ -- Demand AI Group Inc. ("Demand AI"), the fast-growing AI-driven B2B marketing and lead-generation company,…

1 month ago